A strong IP regime is critical for Malaysia

By LOH FOON FONG

PHARMACEUTICAL companies have been accused of making slight modifications to their drugs to extend a patent life span.

This has resulted in calls for the government to not recognise process methods for patenting, and allowing only molecular patents.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Health , Business , Phama , patents

Next In Nation
Two girls reported missing in Santubong, found safe
No political discrimination in policy implementation, says Zahid
Sabah welcomes first direct flight from Shenzhen
Dr Wee highlights MCA's consistent stance amid policy criticism
Bung Moktar’s last Parliament question focused on MA63 progress
Limited seats mean top scorers may miss first choice at public unis
Chinese tourist found dead after plummeting from ninth floor of hotel in Kota Kinabalu
Two children die in separate drowning incidents in Negri Sembilan
Melaka local councils ordered to inspect trees
Dr Wee slams Education Minister for creating obstacles in Chinese school projects

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.